FDA-Inspected Site

Diagnostic Grifols, S.A.

6 FDA inspections are on record for Diagnostic Grifols, S.A. in Parets Del Valles, Spain.

Clean· No action indicated

Parets Del Valles, Spain · Last updated July 9, 2026

Overview

  • 6 FDA inspections are on record.
  • 3 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-05-09.

At a glance

Inspections

6

Form 483s

3

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
5 May 2025 – 9 May 2025BiologicsClean
10 Dec 2018 – 14 Dec 2018BiologicsClean
17 Jul 2017 – 20 Jul 2017Medical Devices & Rad HealthClean
13 Feb 2017 – 16 Feb 2017Medical Devices & Rad Health483View 483 →
3 Nov 2016 – 14 Nov 2016Biologics483On file
22 Jan 2015 – 30 Jan 2015Biologics483On file

Observations on record

Form 483 observations cited at this site, most recent first.

16 Feb 2017
21 CFR 803.50(a)(2)

Report of Malfunction

Cited by Roy Baby

16 Feb 2017
21 CFR 820.250(b)

Sampling plans

Cited by Roy Baby

16 Feb 2017
21 CFR 820.250(b)

Sampling plans

Cited by Roy Baby

16 Feb 2017
21 CFR 820.50(a)(1)

Evaluation and Selection, Suppliers, Contractors, etc.

Cited by Roy Baby

16 Feb 2017
21 CFR 803.50(a)(2)

Report of Malfunction

Cited by Roy Baby

Investigators

FDA investigators tied to this site in the record.

Celeta S Coves1 insp.
Silvia M Blackshire1 insp.
MDSAP harperd1 insp.
Roy Baby1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 803.50(a)(2)Cited across public-safe Form 483 observations2x
21 CFR 820.250(b)Cited across public-safe Form 483 observations2x
21 CFR 820.50(a)(1)Cited across public-safe Form 483 observations2x

Full site report

Get the verbatim findings behind Diagnostic Grifols, S.A.'s 3 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat